Novel Coronavirus (COVID-19)

Aug 12, 2020
The departments of Health and Human Services and Defense will pay Moderna Inc. about $1.5 billion to produce and deliver 100 million doses of its COVID-19 vaccine candidate to vaccinate Americans if authorized by the Food and Drug Administration, the agencies announced.
Aug 12, 2020
The Department of Health and Human Services announced it has expanded the providers eligible for its Public Health and Social Services Emergency Fund “General Distribution.”
Aug 12, 2020
COVID-19 has prompted many changes in the way hospitals manage and care for their patients. As hospitals across the nation deal with the ebb and flow of COVID-19 patients and shortages of ICU beds, North Carolina’s Atrium Health has found a promising solution to increasing their inpatient capacity…
Aug 12, 2020
This AHA Special Bulletin provides details on the Department of Health and Human Services’ announcement that it has expanded the providers eligible for its Public Health and Social Services Emergency Fund “General Distribution.”
Aug 11, 2020
The Delaware health system led webinars on COVID-19 safety for barbershops and salons in underserved communities, donated sanitation kits and shared educational materials.
Aug 11, 2020
Caregivers at INTEGRIS Health, based in Oklahoma City, are featured in a social media campaign about wearing face masks to slow the spread of COVID-19.
Aug 11, 2020
On June 4, Lincoln County Public Health (LCPH) recorded an outbreak of confirmed COVID-19 cases in Newport, Oregon, located about 85 miles southwest of Salem, Oregon. Five of these cases were connected to Pacific Seafood and they immediately began working with LCPH to get their employees tested.
Aug 11, 2020
Houston’s Kindred Healthcare and TIRR Memorial Hermann are among the many post-acute care providers that have incurred increased costs to prepare for and treat COVID-19-positive patients and complex post-COVID-19 patients.
Aug 11, 2020
The Food and Drug Administration authorized the emergency use of George Washington University Public Health Laboratory’s GWU SARS-CoV-2 RT-PCR Test.
Aug 11, 2020
Researchers have launched two clinical trials to test whether monoclonal (laboratory-made) antibodies can safely prevent SARS-CoV-2 infection or symptoms in healthy adults, the National Institutes of Health announced.